Bristol Myers Squibb Co. Stock Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slipped 1.04% to $67.29 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.14% to 3,992.01 and the Dow Jones Industrial Average falling 0.18% to 32,798.40. This was the stock's third consecutive day of losses. Bristol Myers Squibb Co. closed $14.15 short of its 52-week high ($81.44), which the company achieved on December 1st.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.73% to $152.96, Pfizer Inc. (PFE) fell 0.55% to $40.12, and Abbott Laboratories (ABT) fell 0.58% to $99.40. Trading volume (6.0 M) remained 1.9 million below its 50-day average volume of 7.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 8, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 08, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.